October 29, 2026: Fresh concerns over the returns from artificial intelligence weighed on US markets as Alphabet’s latest earnings raised questions about the profitability...

Nucelion Therapeutics will support Pandorum Technologies process development and manufacturing of designer exosomes for investigational therapies targeting advanced keratopathy and wet age-related macular degeneration,...